We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA, 중증 LAD-I 소아 환자 대상 Marne-Cel 승인: 임상시험에서 100% 생존율. Rocket Pharmaceuticals가 거절을 돌파구로 전환한 방법을 알아보세요.
